The new variant is a warning: unless we take urgent action to correct global vaccine inequities, we risk the emergence of further variants, some of which may evade vaccines.
L’expertise universitaire, l’exigence journalistique
Articles sur Omicron variant
Affichage de 141 à 151 de 151 articles
The current spate of travel bans is rather hasty and irrational given that we know that the variant is in several countries already.
If COVID symptoms are less severe, people with the Omicron variant may be less likely to test and isolate.
Investors dumped assets en masse as news of the new COVID variant spread.
The Scanlon Foundation Research Institute’s 2021 Mapping Social Cohesion Report found that while concern about the pandemic ebbs and flows, COVID has not shaken the nation’s social cohesion.
Not much data, but lessons have been learned from the slow response to delta.
With low COVID vaccination coverage in southern Africa, some have suggested global vaccine inequities may be responsible for the emergence of Omicron.
Given the Omicron variant has already spread beyond southern Africa, a ban on travellers from those countries will slow the spread and buy crucial time, but won’t stop this strain in its tracks.
The world needs to learn to live with the virus. And governments must follow the science and don’t distort it for political expediency.
There’s a new COVID lineage called B.1.1.529. It has a genetic profile very different from other circulating variants
Tracking the pandemic’s waves enables authorities and policy makers to take action to keep new waves at bay.
Les contributeurs les plus fréquents
-
Professorial Fellow, University of Canberra
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Associate Professor of Molecular Medicine, UMass Chan Medical School
-
Professor, Infectious Diseases and Microbiology, The University of Queensland
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Medicine, University of East Anglia
-
Professor and Department Chair of Infectious Diseases and Microbiology, University of Pittsburgh
-
Senior Lecturer, Medical Microbiology, University of Westminster
-
Principal Medical Scientist at National Institute for Communicable Diseases (NICD), National Institute for Communicable Diseases
-
Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Canada Research Chair in Aging & Immunity, McMaster University
-
Professor, Biology, York University, Canada
-
Adjunct Professor: Department Internal Medicine, University of Pretoria
-
Director: SACEMA, South African Centre for Epidemiological Modelling & Analysis (SACEMA)
